Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Taku Nakagami"'
Autor:
Norio Sugawara, Masamichi Ishioka, Shoko Tsuchimine, Koji Tsuruga, Yasushi Sato, Hanako Furukori, Shuhei Kudo, Tetsu Tomita, Taku Nakagami, Norio Yasui-Furukori
Publikováno v:
PLoS ONE, Vol 10, Iss 11, p e0143356 (2015)
Although the use of placebo in clinical trials of schizophrenia patients is controversial because of medical and ethical concerns, placebo-controlled clinical trials are commonly used in the licensing of new drugs.The objective of this study was to a
Externí odkaz:
https://doaj.org/article/001ee485aae1475585bbf324b05dcc15
Autor:
Tetsu Tomita, Norio Yasui-Furukori, Taku Nakagami, Shoko Tsuchimine, Masamichi Ishioka, Ayako Kaneda, Norio Sugawara, Sunao Kaneko
Publikováno v:
PLoS ONE, Vol 9, Iss 5, p e98099 (2014)
IntroductionThe efficacy of treatment with selective serotonin reuptake inhibitors in patients with major depressive disorder (MDD) can differ depending on the patient's serotonin transporter-linked polymorphic region (5-HTTLPR) genotype, and the eff
Externí odkaz:
https://doaj.org/article/0574598e14754dafbe870e7926792996
Autor:
Kazutoshi Kubo, Norio Yasui-Furukori, Taku Nakagami, Saaya Yokoyama, Kensuke Miyazaki, Masamichi Ishioka, Norio Sugawara, Natsumi Tarakita, Kazutaka Shimoda
Publikováno v:
Therapeutic Drug Monitoring. 42:766-770
Purpose Valproic acid (VPA) is not only an antiepileptic drug but also a mood stabilizer for patients with bipolar disorder. Long-term VPA therapy can cause carnitine deficiency, which may result in an increase in the blood ammonia level, in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e74ca483e789a40561b5abd9f338f14
https://doi.org/10.1097/ftd.0000000000000778
https://doi.org/10.1097/ftd.0000000000000778
Autor:
Yasushi Kawamata, Norio Sugawara, Masamichi Ishioka, Akira Fujii, Katsuji Suzuki, Hanako Furukori, Taku Nakagami, Norio Yasui-Furukori, Kazutaka Shimoda, Kazutoshi Kubo
Publikováno v:
Neuropsychiatric Disease and Treatment
Yasushi Kawamata,1 Norio Sugawara,1,2 Masamichi Ishioka,3 Kazutoshi Kubo,4 Katsuji Suzuki,5 Akira Fujii,6 Hanako Furukori,7 Taku Nakagami,8 Norio Yasui-Furukori,1,2 Kazutaka Shimoda1 1Department of Psychiatry, Dokkyo Medical University School of Medi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f00454025f0cfba3fac0567d9b5b1fb
https://www.dovepress.com/different-attitudes-of-patients-and-psychiatrists-toward-benzodiazepin-peer-reviewed-fulltext-article-NDT
https://www.dovepress.com/different-attitudes-of-patients-and-psychiatrists-toward-benzodiazepin-peer-reviewed-fulltext-article-NDT
Autor:
Shoko Tsuchimine, Masamichi Ishioka, Ayako Kaneda, Kazuhiko Nakamura, Taku Nakagami, Tetsu Tomita, Norio Yasui-Furukori
Publikováno v:
Neuropsychiatric Disease and Treatment
Tetsu Tomita,1 Norio Yasui-Furukori,1 Taku Nakagami,2 Shoko Tsuchimine,3 Masamichi Ishioka,4 Ayako Kaneda,1 Kazuhiko Nakamura1 1Department of Neuropsychiatry, Graduate School of Medicine, Hirosaki University, Hirosaki, Japan; 2Department of Psychiatr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::362a208ca2697146263f06139a881acc
https://doi.org/10.2147/ndt.s187060
https://doi.org/10.2147/ndt.s187060
Autor:
Shoko Tsuchimine, Norio Yasui-Furukori, Koji Tsuruga, Taku Nakagami, Norio Sugawara, Natsumi Tarakita, Tetsu Tomita, Hanako Furukori, Yasushi Sato, Masamichi Ishioka, Shuhei Kudo
Publikováno v:
Journal of Affective Disorders. 225:313-316
Background Placebo-controlled clinical trials are the standard in the design of clinical studies for the licensing of new drugs. Medical and ethical concerns regarding placebo use still exist in clinical trials of depressed patients. The aim of this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::877bc3d74ac8b11de2675ddc964dcc37
https://doi.org/10.1016/j.jad.2017.08.061
https://doi.org/10.1016/j.jad.2017.08.061
Autor:
Yasushi Sato, Kazuma Danjo, Akira Fujii, Hanako Furukori, Tetsu Tomita, Taku Nakagami, Norio Sugawara, Norio Yasui-Furukori, Kazuyo Kitaoka
Publikováno v:
Neuropsychiatric Disease and Treatment
Norio Sugawara,1,2 Kazuma Danjo,3 Hanako Furukori,4 Yasushi Sato,2,5 Tetsu Tomita,2,6 Akira Fujii,7 Taku Nakagami,2,8 Kazuyo Kitaoka,9 Norio Yasui-Furukori2 1Department of Clinical Epidemiology, Translational Medical Center, National Center of Neurol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ff29785713f91b30bc9752ed0b3c349
http://europepmc.org/articles/PMC5356920
http://europepmc.org/articles/PMC5356920
Publikováno v:
Human Psychopharmacology: Clinical and Experimental. 30:334-340
Previous studies have reported changes in the dimensions of the Temperament and Character Inventory (TCI) after patients with major depressive disorder are treated. We aimed to investigate the changes in the TCI dimensions after paroxetine treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0321d6b224bfdcb5b52bfc60b8d3ac41
https://doi.org/10.1002/hup.2479
https://doi.org/10.1002/hup.2479
Autor:
Yasushi Sato, Sunao Kaneko, Norio Yasui-Furukori, Tetsu Tomita, Kazuhiko Nakamura, Taku Nakagami, Shoko Tsuchimine, Ayako Kaneda
Publikováno v:
Clinical Neuropharmacology. 38:6-10
We investigated the effects of age on the association between early and eventual responses to paroxetine treatment in patients with major depressive disorder (MDD).Eighty-nine patients with MDD were administered paroxetine and completed the 6-week pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::628d96d2fa48f5e4a8ddd87c4c10b8c2
https://doi.org/10.1097/wnf.0000000000000058
https://doi.org/10.1097/wnf.0000000000000058
Autor:
Norio Yasui-Furukori, Masamichi Ishioka, Taku Nakagami, Ayako Kaneda, Norio Sugawara, Kazuhiko Nakamura, Tetsu Tomita
Publikováno v:
Journal of Affective Disorders. 165:109-113
Background Previous studies have reported associations between Temperament and Character Inventory (TCI) dimension scores and the response to treatment in patients with major depressive disorder (MDD). We aimed to determine which TCI items could pred
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c74a0165c7c17125e77f9d0d87f59005
https://doi.org/10.1016/j.jad.2014.04.076
https://doi.org/10.1016/j.jad.2014.04.076